Scanning and combinatorial library services – Save 20% with code TRY-BXPLIB-20

Overcoming Process Bottlenecks in Antibody Discovery through End-to-end Automated Synthetic Biology Solutions

Presentation

Overcoming Process Bottlenecks in Antibody Discovery through End-to-end Automated Synthetic Biology Solutions

Presentation, US Antibody Engineering Therapeutics Conference

In this presentation, you will learn how:

  • Construct synthesis is a bottleneck is antibody therapeutic development
  • Recent advances in automation and synthetic biology are addressing this problem
  • The BioXp® system is helping researchers to bridge the automation gap between high content sequencing and downstream characterization

Telesis Bio’s BioXp automation platform streamlines screening and optimization workflows of antibody candidates by enabling high-throughput, overnight fragment synthesis, cloning, as well as generation of antibody variant libraries, all at the push of a button.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.

Your personal data is handled according to our privacy policy. In accordance with California data privacy laws, California residents may obtain information about the categories of personal information we are collecting and the purposes for which personal information is collected and used here: California Privacy Policy. In addition, if you are located within a distributor territory, you may be contacted directly by them.